Published November 23, 2018
| Version v1
Dataset
Open
USP5 Expression and Purification & Development of a Mass Spectrometry USP5 Catalytic Activity Assay
Authors/Creators
- 1. University of Toronto, Structural Genomics Consortium
Description
Expression and purification of full length USP51-835 for optimization of a mass spectrometry (MS) based assay to detect polyubiquitin cleavage
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.